کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
3371497 1219200 2016 10 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Probiotics and synbiotics for the prevention of postoperative infections following abdominal surgery: a systematic review and meta-analysis of randomized controlled trials
ترجمه فارسی عنوان
پروبیوتیک ها و سین بیوتیک ها برای پیشگیری از عفونت های بعد از عمل جراحی شکم: بررسی منظم و متاآنالیز آزمایشات تصادفی کنترل شده
کلمات کلیدی
جراحی شکم عفونت های پست جراحی، جلوگیری، پروبیوتیک ها، عفونت های جراحی، سین بیوتیک ها
موضوعات مرتبط
علوم زیستی و بیوفناوری ایمنی شناسی و میکروب شناسی میکروبیولوژی و بیوتکنولوژی کاربردی
چکیده انگلیسی

SummaryBackgroundPostoperative infections, particularly surgical site infections (SSIs), cause significant morbidity and mortality. Probiotics or synbiotics are a potential prevention strategy.AimTo evaluate the efficacy of probiotics/synbiotics for reducing postoperative infection risk following abdominal surgery.MethodsWe searched AMED, Central, CINAHL, Embase, Medline, and grey literature for randomized controlled trials of elective abdominal surgery patients administered probiotics or synbiotics compared to placebo or standard care. Primary outcome was SSIs. Secondary outcomes were adverse events, respiratory tract infections (RTIs), urinary tract infections (UTIs), combined infections, length of hospital stay, and mortality. Using random-effects meta-analyses, we estimated the relative risk (RR) or mean difference (MD) and 95% confidence interval (CI). Tests were performed for heterogeneity, subgroup and sensitivity analyses were conducted, and the overall evidence quality was graded.FindingsWe identified 20 trials (N = 1374 participants) reporting postoperative infections. Probiotics/synbiotics reduced SSIs (RR: 0.63; 95% CI: 0.41–0.98; N = 15 studies), UTIs (RR: 0.29; 95% CI: 0.15–0.57; N = 11), and combined infections (RR: 0.49; 95% CI: 0.35–0.70; N = 18). There was no difference between groups for adverse events (RR: 0.89; 95% CI: 0.61–1.30; N = 6), RTIs (RR: 0.60; 95% CI: 0.36–1.00; N = 14), length of stay (MD: −1.19; 95% CI: −2.94 to 0.56; N = 12), or mortality (RR: 1.20; 95% CI: 0.58–2.48; N = 15).ConclusionOur review suggests that probiotics/synbiotics reduce SSIs and UTIs from abdominal surgeries compared to placebo or standard of care, without evidence of safety risk. Overall study quality was low, owing mostly to imprecision (few patients and events, or wide CIs); thus larger multi-centered trials are needed to further assess the certainty in this estimate.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Journal of Hospital Infection - Volume 92, Issue 2, February 2016, Pages 130–139
نویسندگان
, , , , ,